Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma. (Q50417609)
Jump to navigation
Jump to search
scientific article published on 28 August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma. |
scientific article published on 28 August 2015 |
Statements
1 reference
Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma. (English)
1 reference
Lee Ratner
1 reference
JC Ramos
1 reference
Ariela Noy
1 reference
Stefan Barta
1 reference
Samir Parikh
1 reference
Adrienne Phillips
1 reference
Richard Ambinder
1 reference
Dan Rauch
1 reference
John Harding
1 reference
Hicham Baydoun
1 reference
Xiaogang Cheng
1 reference
Breanna Caruso
1 reference
Steven Jacobson
1 reference
28 August 2015
1 reference
1 reference
12
1 reference
Suppl 1
1 reference
P21-P21
1 reference
Identifiers
1 reference
1 reference